env
Loading...Anti-env Products
+ Filter
Loading...-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: Neut, ELISA
-
- Species Reactivity: DENV
- Type: Human IgG
- Application: Neut
-
- Derivation: Mouse
- Species Reactivity: DENV
- Type: IgG
- Application: WB, IHC, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: DENV
- Type: IgG
- Application: Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: Neut, ELISA
-
- Species Reactivity: DENV
- Type: Human IgG
- Application: ELISA
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: ELISA, Neut
-
- Species Reactivity: SIV, HIV1
- Type: Human IgG
- Application: Neut
-
- Derivation: Human
- Species Reactivity: DENV
- Type: IgG
- Application: Neut
-
- Species Reactivity: DENV
- Type: Human IgG
- Application: Neut
- PE-H-2Dd/HIV Env (IPGRAFYA) MHC Tetramer (MHC-CN0617)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: IPGRAFYA
- Conjugate: PE
- APC-H-2Dd/HIV Env (IPGRAFYA) MHC Tetramer (MHC-CN0618)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: IPGRAFYA
- Conjugate: APC
- FITC-H-2Dd/HIV Env (IPGRAFYA) MHC Tetramer (MHC-CN0619)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: IPGRAFYA
- Conjugate: FITC
- H-2Dd/HIV Env (IPGRAFYA) MHC Tetramer (MHC-CN0620)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: IPGRAFYA
- Conjugate: Unconjugated
- PE-A*02:01/HIV Env (NVWATHACV) MHC Tetramer (MHC-CN0621)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: NVWATHACV
- Conjugate: PE
- APC-A*02:01/HIV Env (NVWATHACV) MHC Tetramer (MHC-CN0622)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: NVWATHACV
- Conjugate: APC
- FITC-A*02:01/HIV Env (NVWATHACV) MHC Tetramer (MHC-CN0623)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: NVWATHACV
- Conjugate: FITC
- A*02:01/HIV Env (NVWATHACV) MHC Tetramer (MHC-CN0624)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: NVWATHACV
- Conjugate: Unconjugated
- PE-A*02:01/HIV Env (SLLNATAIAV) MHC Tetramer (MHC-CN0625)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: SLLNATAIAV
- Conjugate: PE
- APC-A*02:01/HIV Env (SLLNATAIAV) MHC Tetramer (MHC-CN0626)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: SLLNATAIAV
- Conjugate: APC
- FITC-A*02:01/HIV Env (SLLNATAIAV) MHC Tetramer (MHC-CN0627)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: SLLNATAIAV
- Conjugate: FITC
- A*02:01/HIV Env (SLLNATAIAV) MHC Tetramer (MHC-CN0628)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: SLLNATAIAV
- Conjugate: Unconjugated
- Human Anti-Env Antibody, mRNA (PABL-193-mRNA)
-
- Species Reactivity: Human immunodeficiency virus 1
- Recombinant Human Anti-Env Soluble TCR (AF12) (C-Cys) (VS-0622-YF3847)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (AF4) (C-Cys) (VS-0622-YF3848)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Mouse Anti-Env Recombinant Soluble TCR (clone B4.2.3) (scTCR-0346YC-S(P))
-
- Species Reactivity: HIV1
- Epitope: RGPGRAFVTI
- MHC: H2-D1
- FITC-B*08:01/HIV Env (YLKDQQLL) MHC Tetramer (MHC-CN0631)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: YLKDQQLL
- Conjugate: FITC
- Recombinant Human Anti-Env Soluble TCR (AF4) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1140)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (BB1) (C-Cys) (VS-0622-YF3849)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (BB1) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1141)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- B*08:01/HIV Env (YLKDQQLL) MHC Tetramer (MHC-CN0632)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: YLKDQQLL
- Conjugate: Unconjugated
- Recombinant Human Anti-Env Soluble TCR (WH3) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1142)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (AF12) (KIH) (VS-0622-YF6555)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (WH3) (C-Cys) (VS-0622-YF3850)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Human Anti-Env Soluble TCR (AF4) (KIH) (VS-0622-YF6556)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- PE-A*29:02/HIV Env (SFDPIPIHY) MHC Tetramer (MHC-CN0633)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: SFDPIPIHY
- Conjugate: PE
- Recombinant Human Anti-Env Soluble TCR (BB1) (KIH) (VS-0622-YF6557)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Mouse Anti-Env Soluble TCR (B4.2.3) (KIH) (VS-0622-YF6312)
-
- Species Reactivity: HIV1
- Epitope: RGPGRAFVTI
- MHC: HLA A*02
- Recombinant Human Anti-Env Soluble TCR (WH3) (KIH) (VS-0622-YF6558)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
- Recombinant Anti-Env Soluble TCR (bispecific TCR) (KIH) (VS-0622-YF6313)
-
- Species Reactivity: HIV1
- Epitope: KLTPLCVTL
- MHC: HLA A*02
- Recombinant Anti-Env Soluble TCR (bispecific TCR A117G) (KIH) (VS-0622-YF6314)
-
- Species Reactivity: HIV1
- Epitope: KLTPLCVTL
- MHC: HLA A*02
-
- Derivation: Human
- Species Reactivity: HPV
- Type: IgG
- Application: WB, IF, FuncS
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: FACS, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: Neut, FuncS
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: FACS, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: IgG
- Application: FACS, Neut
- H-2Db/LCMV gp (KAVYNFATC) MHC Monomer (MHC-YF188)
-
- Class: Class I
- Antigen: gp
- Antigen Species: LCMV
- Peptide: KAVYNFATC
- Conjugate: Biotin
- H-2Db/LCMV gp (SGVENPGGYCL) MHC Monomer (MHC-YF189)
-
- Class: Class I
- Antigen: gp
- Antigen Species: LCMV
- Peptide: SGVENPGGYCL
- Conjugate: Biotin
- H-2Kb/LCMV gp (AVYNFATC) MHC Monomer (MHC-YF194)
-
- Class: Class I
- Antigen: gp
- Antigen Species: LCMV
- Peptide: AVYNFATC
- Conjugate: Biotin
- H-2Kb/LCMV gp (AVYNFATCGI) MHC Monomer (MHC-YF195)
-
- Class: Class I
- Antigen: gp
- Antigen Species: LCMV
- Peptide: AVYNFATCGI
- Conjugate: Biotin
- H-2Kb/LCMV gp (ISHNFCNL) MHC Monomer (MHC-YF196)
-
- Class: Class I
- Antigen: gp
- Antigen Species: LCMV
- Peptide: ISHNFCNL
- Conjugate: Biotin
- Human Anti-Env Antibody, mRNA (FAMAB-1788CQ-mRNA) (FAMAB-1788CQ-mRNA)
-
- Species Reactivity: DENV, ZIKV
- Human Anti-Env Antibody (PABL-438-mRNA), mRNA (PABL-438-mRNA)
-
- Species Reactivity: Dengue virus
- Human Anti-Env Antibody (clone PGT123), mRNA (PABZ-160-mRNA)
-
- Species Reactivity: Human immunodeficiency virus 1
- Mouse Anti-Env Antibody (clone Mab513), mRNA (PABL-442-mRNA)
-
- Species Reactivity: Dengue virus
- Human Anti-Env Antibody (clone PGT122), mRNA (PABZ-161-mRNA)
-
- Species Reactivity: Human immunodeficiency virus 1
- Recombinant Mouse Anti-Env Soluble TCR (EF4.1) (KIH) (VS-0622-YF7064)
-
- Species Reactivity: MuLV
- Epitope: EPLTSLTPRCNTAWNRLKL
- MHC: H2-b
- Human Anti-Env Antibody (clone mAb-94), mRNA (PABL-577-mRNA)
-
- Species Reactivity: HPV
- Human Anti-Env Antibody (clone PGT 135), mRNA (PABZ-168-mRNA)
-
- Species Reactivity: Human immunodeficiency virus 1
- PE-B*08:01/HIV Env (YLKDQQLL) MHC Tetramer (MHC-CN0629)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: YLKDQQLL
- Conjugate: PE
- Human Anti-Env Antibody (clone PGT121), mRNA (PABZ-203-mRNA)
-
- Species Reactivity: Human immunodeficiency virus 1
- APC-B*08:01/HIV Env (YLKDQQLL) MHC Tetramer (MHC-CN0630)
-
- Class: Class I
- Antigen: Env
- Antigen Species: HIV
- Peptide: YLKDQQLL
- Conjugate: APC
- Recombinant Mouse Anti-Env Soluble TCR (EF4.1) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1648)
-
- Species Reactivity: MuLV
- Epitope: EPLTSLTPRCNTAWNRLKL
- MHC: H2-b
- Recombinant Human Anti-Env Soluble TCR (AF12) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1139)
-
- Species Reactivity: Hepatitis B virus
- Epitope: WLSLLVPFV
- MHC: HLA-A*02:01
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: Neut, ELISA
- anti-env immunotoxin 907 (IgG)-RTA (AGTO-L012R)
-
- Species Reactivity: HIV
- Application: Cytotoxicity assay, Functional assay
- CH2 domain scaffold protein anti-HIV Env (SCH-L059)
-
- Scaffold Name: CH2 domain
- Target: Env
- Species Reactivity: HIV
- Derivation: Phage display
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: Neut, FuncS
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: Neut, FuncS
-
- Derivation: Llama
- Species Reactivity: HIV
- Type: Llama VHH
- Application: ELISA, SPR, Neut, FuncS
-
- Derivation: Llama
- Species Reactivity: HIV-1
- Type: Llama VHH
- Application: Neut, WB, ELISA, FuncS
-
- Derivation: Llama
- Species Reactivity: HIV-1
- Type: Llama VHH
- Application: ELISA, Inhib
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: Neut, ELISA
-
- Species Reactivity: SIV, HIV1
- Type: Human Fab
- Application: Neut
-
- Derivation: Human
- Species Reactivity: DENV
- Type: Fab
- Application: Neut
-
- Species Reactivity: DENV
- Type: Human Fab
- Application: Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: FACS, Neut
-
- Species Reactivity: DENV
- Type: Human Fab
- Application: Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: ELISA, Neut
-
- Species Reactivity: DENV
- Type: Human Fab
- Application: Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: FACS, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: DENV
- Type: scFv
- Application: Neut
-
- Species Reactivity: DENV
- Type: Human scFv
- Application: Neut
-
- Species Reactivity: SIV, HIV1
- Type: Human scFv
- Application: Neut
-
- Species Reactivity: DENV
- Type: Human scFv
- Application: Neut
-
- Species Reactivity: DENV
- Type: Human scFv
- Application: Neut
-
- Derivation: Mouse
- Species Reactivity: DENV
- Type: scFv
- Application: WB, IHC, IF, FuncS
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: FACS, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: ELISA, Neut
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: scFv
- Application: FuncS
-
- Derivation: Human
- Species Reactivity: HPV
- Type: Fab
- Application: WB, IF, FuncS
-
- Derivation: Mouse
- Species Reactivity: DENV
- Type: scFv
- Application: WB, ELISA, FuncS
-
- Derivation: Human
- Species Reactivity: HIV-1
- Type: Fab
- Application: ELISA, Neut
- Mouse Anti-env Recombinant Antibody (clone 2506W0384) (VS-0625-FY489)
-
- Species Reactivity: Human immunodeficiency virus 1 (HIV-1)
- Type: Mouse IgG
- Application: ELISA
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Envelope glycoprotein gp160 is a precursor protein encoded by HIV-1. It is cleaved into gp120 (surface glycoprotein) and gp41 (transmembrane glycoprotein). gp120 mediates binding to host CD4 receptors and coreceptors, while gp41 facilitates fusion of the viral and host cell membranes, allowing viral entry. It is a major target for vaccine development.

